Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency.

Area of Science:

• Immunology
• Infectious Diseases
• Pulmonology

Background:

• Patients with common variable immunodeficiency (CVID) experience frequent respiratory infections despite immunoglobulin therapy, leading to substantial antibiotic use.
• The clinical characteristics, triggers for antibiotic use, and treatment responses for CVID-related respiratory exacerbations remain under-investigated.

Purpose of the Study:

• To characterize the nature, frequency, and clinical course of respiratory exacerbations in CVID patients.
• To identify pathogens involved in these exacerbations and analyze antibiotic treatment patterns.

Main Methods:

• A prospective diary study was conducted with 69 CVID patients over 6210 days.
• Microbiology and virology samples were collected from symptomatic patients, including sputum analysis and PCR for respiratory viruses.

Main Results:

• 170 symptomatic exacerbations and 76 antibiotic treatments were recorded. Cough, shortness of breath, and purulent sputum predicted antibiotic initiation, with a median 5-day delay.
• Viral pathogens were identified in 56% of exacerbations, and bacteria in 33%. Purulent sputum episodes responded faster to antibiotics than upper respiratory symptoms.

Conclusions:

• CVID patients exhibit treatment delays for respiratory exacerbations, risking lung damage.
• The high prevalence of viruses and poor response to antibiotics for upper respiratory symptoms suggest a need for more targeted antibiotic stewardship in CVID.